Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Intestinal Inhibition of the Na + /H + Exchanger 3 Prevents Cardiorenal Damage in Rats and Inhibits Na + Uptake in Humans
Andrew Spencer, Eric D. Labonté, David P. Rosenbaum, et al.
Science Translational Medicine (2014) Vol. 6, Iss. 227
Closed Access | Times Cited: 142

Showing 26-50 of 142 citing articles:

Visceral Congestion in Heart Failure: Right Ventricular Dysfunction, Splanchnic Hemodynamics, and the Intestinal Microenvironment
Vincenzo B. Polsinelli, Arjun Sinha, Sanjiv J. Shah
Current Heart Failure Reports (2017) Vol. 14, Iss. 6, pp. 519-528
Open Access | Times Cited: 52
A phase 1 study of the safety, tolerability, pharmacodynamics, and pharmacokinetics of tenapanor in healthy Japanese volunteers
Susanne Johansson, David P. Rosenbaum, Mikael Knutsson, et al.
Clinical and Experimental Nephrology (2016) Vol. 21, Iss. 3, pp. 407-416
Open Access | Times Cited: 51
New therapeutic perspectives in irritable bowel syndrome: Targeting low-grade inflammation, immuno-neuroendocrine axis, motility, secretion and beyond
Emanuele Sinagra, Gaetano Cristian Morreale, Ghazaleh Mohammadian, et al.
World Journal of Gastroenterology (2017) Vol. 23, Iss. 36, pp. 6593-6627
Open Access | Times Cited: 49
Pharmacodynamics, Safety, and Tolerability of the NHE3 Inhibitor Tenapanor: Two Trials in Healthy Volunteers
David P. Rosenbaum, Andrew T. Yan, Jeffrey Jacobs
Clinical Drug Investigation (2018) Vol. 38, Iss. 4, pp. 341-351
Open Access | Times Cited: 48
Efficacy of Tenapanor in Treating Patients With Irritable Bowel Syndrome With Constipation: A 26-Week, Placebo-Controlled Phase 3 Trial (T3MPO-2)
William D. Chey, Anthony Lembo, Yang Yang, et al.
The American Journal of Gastroenterology (2020) Vol. 116, Iss. 6, pp. 1294-1303
Open Access | Times Cited: 48
New drug targets for hypertension: A literature review
Qiannan Gao, Li Xu, Jun Cai
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2020) Vol. 1867, Iss. 3, pp. 166037-166037
Open Access | Times Cited: 44
The Na+/H+ Exchanger 3 in the Intestines and the Proximal Tubule of the Kidney: Localization, Physiological Function, and Key Roles in Angiotensin II-Induced Hypertension
Sarah M. Nwia, Xiao-Chun Li, Ana Paula de Oliveira Leite, et al.
Frontiers in Physiology (2022) Vol. 13
Open Access | Times Cited: 28
Interventional procedures and future drug therapy for hypertension
Melvin D. Lobo, Paul A. Sobotka, Atul Pathak
European Heart Journal (2016), pp. ehw303-ehw303
Open Access | Times Cited: 47
Chronic constipation: Update on management
Umar Hayat, Mohannad Dugum, Samita Garg
Cleveland Clinic Journal of Medicine (2017) Vol. 84, Iss. 5, pp. 397-408
Open Access | Times Cited: 44
Elucidating an Amorphous Form Stabilization Mechanism for Tenapanor Hydrochloride: Crystal Structure Analysis Using X-ray Diffraction, NMR Crystallography, and Molecular Modeling
Sten O. Nilsson Lill, Cory M. Widdifield, Anna Pettersen, et al.
Molecular Pharmaceutics (2018) Vol. 15, Iss. 4, pp. 1476-1487
Open Access | Times Cited: 38
The effects of tenapanor on serum fibroblast growth factor 23 in patients receiving hemodialysis with hyperphosphatemia
Geoffrey A. Block, David P. Rosenbaum, Andrew T. Yan, et al.
Nephrology Dialysis Transplantation (2018) Vol. 34, Iss. 2, pp. 339-346
Open Access | Times Cited: 36
Intestinal phosphate absorption: The paracellular pathway predominates?
Matthew Saurette, R. Todd Alexander
Experimental Biology and Medicine (2019) Vol. 244, Iss. 8, pp. 646-654
Open Access | Times Cited: 35
Novel developments in differentiating the role of renal and intestinal sodium hydrogen exchanger 3
Jessica A. Dominguez, Samantha de la Mora Chavez, Timo Rieg
AJP Regulatory Integrative and Comparative Physiology (2016) Vol. 311, Iss. 6, pp. R1186-R1191
Open Access | Times Cited: 34
Safety and Efficacy of Tenapanor for Long-term Serum Phosphate Control in Maintenance Dialysis: A 52-Week Randomized Phase 3 Trial (PHREEDOM)
Geoffrey A. Block, Anthony J. Bleyer, Arnold L. Silva, et al.
Kidney360 (2021) Vol. 2, Iss. 10, pp. 1600-1610
Open Access | Times Cited: 26
Systematic review and network meta‐analysis: efficacy of licensed drugs for abdominal bloating in irritable bowel syndrome with constipation
Alfred D. Nelson, Christopher J. Black, Lesley A. Houghton, et al.
Alimentary Pharmacology & Therapeutics (2021) Vol. 54, Iss. 2, pp. 98-108
Open Access | Times Cited: 25
Tenapanor in the Treatment of Irritable Bowel Syndrome with Constipation: Discovery, Efficacy, and Role in Management
Anam Herekar, Dhanush Shimoga, Asad Jehangir, et al.
Clinical and Experimental Gastroenterology (2023) Vol. Volume 16, pp. 79-85
Open Access | Times Cited: 10
Tenapanor: A novel therapeutic agent for dialysis patients with hyperphosphatemia
Tadao Akizawa, Natsuki Urano, Kazuaki Ikejiri, et al.
Therapeutic Apheresis and Dialysis (2025)
Open Access
Novel approaches in antihypertensive pharmacotherapeutics
Mazlum Çöpür, Alexandru Burlacu, Mehmet Kanbay
Current Opinion in Nephrology & Hypertension (2025)
Closed Access
Euvolemia in Hemodialysis Patients: A Potentially Dangerous Goal?
Shih‐Han S. Huang, Guido Filler, Robert M. Lindsay, et al.
Seminars in Dialysis (2014) Vol. 28, Iss. 1, pp. 1-5
Open Access | Times Cited: 34
Gastrointestinal–Renal Axis: Role in the Regulation of Blood Pressure
Jian Yang, Pedro A. José, Chunyu Zeng
Journal of the American Heart Association (2017) Vol. 6, Iss. 3
Open Access | Times Cited: 32
Role of enteroendocrine L‐cells in arginine vasopressin‐mediated inhibition of colonic anion secretion
Ramona Pais, Juraj Rievaj, Claire L. Meek, et al.
The Journal of Physiology (2016) Vol. 594, Iss. 17, pp. 4865-4878
Open Access | Times Cited: 31
Effect of Tenapanor on Interdialytic Weight Gain in Patients on Hemodialysis
Geoffrey A. Block, David P. Rosenbaum, Maria Leonsson‐Zachrisson, et al.
Clinical Journal of the American Society of Nephrology (2016) Vol. 11, Iss. 9, pp. 1597-1605
Open Access | Times Cited: 29
Targeting Gastrointestinal Transport Proteins to Control Hyperphosphatemia in Chronic Kidney Disease
Denis Fouque, Marc Vervloet, Markus Ketteler
Drugs (2018) Vol. 78, Iss. 12, pp. 1171-1186
Open Access | Times Cited: 28
Linaclotide improves gastrointestinal transit in cystic fibrosis mice by inhibiting sodium/hydrogen exchanger 3
Daniel R. McHugh, Calvin U. Cotton, Fraser J. Moss, et al.
AJP Gastrointestinal and Liver Physiology (2018) Vol. 315, Iss. 5, pp. G868-G878
Open Access | Times Cited: 28
Enhanced phosphate absorption in intestinal epithelial cell‐specific NHE3 knockout mice
Jianxiang Xue, Linto Thomas, Sathish K. Murali, et al.
Acta Physiologica (2022) Vol. 234, Iss. 2
Open Access | Times Cited: 16

Scroll to top